A recent study from the JAMA identified safety concerns about the fast-tracking of three drugs. One was Gilenya. I'm wondering if you could comment on that, Mrs. Sabourin.
On October 18th, 2012. See this statement in context.
On October 18th, 2012. See this statement in context.
October 18th, 2012 / 12:35 p.m.
Liberal
Kirsty Duncan Liberal Etobicoke North, ON
A recent study from the JAMA identified safety concerns about the fast-tracking of three drugs. One was Gilenya. I'm wondering if you could comment on that, Mrs. Sabourin.
See context to find out what was said next.